Lasa Supergenerics informs about board meeting

04 Nov 2019 Evaluate

Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, Lasa Supergenerics has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 12, 2019 at 11.00 am (IST) at the Corporate Office of the Company, to consider, approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter/ half year ended September 30, 2019, and/ or to discuss any other business/ matter with the permission of the Chairman. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s Code of Conduct, the Trading Window shall continue to remain closed till November 15, 2019. Pursuant to Regulation 47(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company is also taking step to issue public notice in English Language and in the daily newspaper published in the language of the region. This Intimation is also available on the company’s website at www.lasalabs.com and on the website of the stock Exchange at www.bseindia.com and www.nseindia.com.

The above information is a part of company’s filings submitted to BSE.

Lasa Supergenerics Share Price

22.44 -0.20 (-0.88%)
29-May-2024 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1480.00
Dr. Reddys Lab 5971.45
Cipla 1482.15
Zydus Lifesciences 1043.95
Lupin 1598.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.